An FDA advisory panel gave the green light to the drug, which treats epilepsy, and the full agency is expected to give its approval, as well, sometime in June.
from Kaiser Health News https://ift.tt/2J9Le4G
April 20, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Different Takes: The Assaults On The ACA Create ‘Risks For Everyone’; Congress Steps Up On CHIP, But Other Issues Still UnresolvedEdidtorial pages feature thoughts on these topics as well as perspectives on state developments regarding Medicaid eligibility and expansion. from Kaiser Health News http://ift.tt/2E1JhWM … Read More
Hospitals’ Best-Laid Plans Upended By Disaster… Read More
State Highlights: Mass.’s New Health Plan Limits Irk Unions; Ark. Nursing Home ‘Failed’ To Address InfestationMedia outlets report on news from Vermont, Florida, Minnesota, Wisconsin, Georgia, Maryland and Michigan. from Kaiser Health News http://ift.tt/2DvuKRY … Read More
Viewpoints: Letting People Opt Out Of The ACA Is Dangerous For All; CHIP Passes But ‘Urgent’ Issues RemainOpinion writers from around the country weigh in on a range of health care issues. from Kaiser Health News http://ift.tt/2DudCfm … Read More
Ultrasounds Are Next Up On Minn. Anti-Abortion Group’s AgendaAbortion rights groups, however, say any legislation requiring centers to ask if women want to see their ultrasounds would be redundant. “Doctors ought to be giving their patients all the information they can to make an infor… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment